Citadel Advisors’s Alto Ingredients ALTO Stock Holding History

Citadel Advisors’s Portfolio ALTO Stock Details ALTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$236K	Buy	48,700 +9,600	+25%	+$30.5K	﹤0.01%	11056
2025 Q4	$113K	Sell	39,100 -46,500	-54%	-$87.7K	﹤0.01%	11537
2025 Q3	$92.4K	Buy	85,600 +30,300	+55%	+$34.1K	﹤0.01%	11893
2025 Q2	$63.6K	Sell	55,300 -48,200	-47%	-$46.2K	﹤0.01%	11649
2025 Q1	$118K	Buy	103,500 +83,400	+415%	+$129K	﹤0.01%	11231
2024 Q4	$31.4K	Sell	20,100 -10,500	-34%	-$16.5K	﹤0.01%	12832
2024 Q3	$49.3K	Buy	30,600 +7,200	+31%	+$10.8K	﹤0.01%	11933
2024 Q2	$33.8K	Sell	23,400 -9,800	-30%	-$16.9K	﹤0.01%	12155
2024 Q1	$72.4K	Sell	33,200 -63,000	-65%	-$133K	﹤0.01%	11778
2023 Q4	$256K	Sell	96,200 -47,700	-33%	-$152K	﹤0.01%	9478
2023 Q3	$636K	Buy	143,900 +55,600	+63%	+$215K	﹤0.01%	7545
2023 Q2	$255K	Sell	88,300 -1,000	-1%	-$1.91K	﹤0.01%	9367
2023 Q1	$134K	Sell	89,300 -46,500	-34%	-$127K	﹤0.01%	10825
2022 Q4	$391K	Buy	135,800 +81,900	+152%	+$291K	﹤0.01%	8762
2022 Q3	$196K	Buy	53,900 +23,400	+77%	+$98.5K	﹤0.01%	10419
2022 Q2	$113K	Sell	30,500 -28,200	-48%	-$147K	﹤0.01%	11293
2022 Q1	$400K	Sell	58,700 -44,000	-43%	-$246K	﹤0.01%	9896
2021 Q4	$494K	Sell	102,700 -88,700	-46%	-$466K	﹤0.01%	9725
2021 Q3	$946K	Buy	191,400 +61,700	+48%	+$311K	﹤0.01%	8299
2021 Q2	$792K	Sell	129,700 -24,700	-16%	-$144K	﹤0.01%	8968
2021 Q1	$838K	Buy	154,400 +33,400	+28%	+$221K	﹤0.01%	8536
2020 Q4	$657K	Buy	121,000 +42,800	+55%	+$297K	﹤0.01%	7627
2020 Q3	$572K	Buy	+78,200	New	+$271K	﹤0.01%	7053
2019 Q3	–	Sell	-39,100	Closed	-$30K	–	9110
2019 Q2	$30K	Sell	39,100 -17,100	-30%	-$17.4K	﹤0.01%	8873
2019 Q1	$55K	Buy	56,200 +40,000	+247%	+$47K	﹤0.01%	8786
2018 Q4	$14K	Sell	16,200 -31,900	-66%	-$52.7K	﹤0.01%	8853
2018 Q3	$91K	Buy	48,100 +6,200	+15%	+$13.9K	﹤0.01%	8606
2018 Q2	$109K	Sell	41,900 -6,900	-14%	-$22K	﹤0.01%	8200
2018 Q1	$146K	Buy	48,800 +38,200	+360%	+$153K	﹤0.01%	7554
2017 Q4	$48K	Sell	10,600 -27,200	-72%	-$129K	﹤0.01%	7643
2017 Q3	$210K	Sell	37,800 -9,800	-21%	-$53.4K	﹤0.01%	6624
2017 Q2	$298K	Sell	47,600 -5,200	-10%	-$33.7K	﹤0.01%	5925
2017 Q1	$362K	Buy	52,800 +15,200	+40%	+$116K	﹤0.01%	5584
2016 Q4	$357K	Sell	37,600 -24,400	-39%	-$196K	﹤0.01%	5424
2016 Q3	$428K	Buy	62,000 +19,500	+46%	+$126K	﹤0.01%	5097
2016 Q2	$232K	Buy	42,500 +14,600	+52%	+$72.5K	﹤0.01%	5603
2016 Q1	$131K	Sell	27,900 -5,300	-16%	-$20.8K	﹤0.01%	5900
2015 Q4	$159K	Buy	33,200 +15,200	+84%	+$79.5K	﹤0.01%	6117
2015 Q3	$117K	Sell	18,000 -19,800	-52%	-$151K	﹤0.01%	6803
2015 Q2	$390K	Sell	37,800 -31,400	-45%	-$362K	﹤0.01%	5353
2015 Q1	$747K	Buy	69,200 +14,600	+27%	+$141K	﹤0.01%	4336
2014 Q4	$564K	Sell	54,600 -23,700	-30%	-$289K	﹤0.01%	4557
2014 Q3	$1.09M	Buy	78,300 +28,700	+58%	+$540K	﹤0.01%	3602
2014 Q2	$758K	Sell	49,600 -14,600	-23%	-$202K	﹤0.01%	3850
2014 Q1	$999K	Buy	64,200 +48,800	+317%	+$492K	﹤0.01%	3424
2013 Q4	$78K	Buy	+15,400	New	+$57.3K	﹤0.01%	5785

Other funds holding ALTO

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

Citadel Advisors's ALTO Position: Q1 2026 in Review

Citadel Advisors increased its Alto Ingredients (ALTO) stake by 70% in Q1 2026, buying an estimated $425K and bringing the position to 324,286 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #6617.

Citadel Advisors first reported a position in ALTO in Q1 2014 and has held it in 47 quarters since. The position peaked at $4.37M in Q3 2022. 102 funds tracked by Wall St. Rank hold ALTO as of Q1 2026.

Citadel Advisors held 324,286 shares of Alto Ingredients worth $1.57M as of Q1 2026.
Citadel Advisors bought 133,864 Alto Ingredients shares in Q1 2026, an estimated $425K.
Alto Ingredients made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6617 holding.
Citadel Advisors first reported a position in Alto Ingredients in Q1 2014 and has held it in 47 quarters since.
Citadel Advisors's Alto Ingredients position peaked at $4.37M in Q3 2022.
102 funds tracked by Wall St. Rank held Alto Ingredients as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.